Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Amgen Sued On US Stelara Biosimilar After Providing May 2023 Intent
Janssen Alleges Compound And UC Patents Infringed By ABP 654 Biosimilar
01 Dec 2022
•
By
Dean Rudge
Amgen targets ustekinumab among the next wave • Source: Alamy/Marlon Trottmann
More from Biosimilars
More from Products